| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $262.60M | $263.40M | $78.50M | $131.40M | $46.70M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $381.10M | $513.60M | $480.00M | $394.60M | $242.00M |
| R&D | $285.20M | $348.20M | $379.70M | $315.00M | $180.40M |
| SG&A | $95.90M | $165.40M | $100.30M | $79.60M | $61.60M |
| Operating Income | -$118.50M | -$250.20M | -$401.50M | -$263.20M | -$195.30M |
| Interest Expense | – | $0.00 | $0.00 | $0.00 | $100.00K |
| Tax Expense | $300.00K | $600.00K | $900.00K | $20.90M | $0.00 |
| Net Income | -$80.80M | -$198.90M | -$367.30M | -$282.50M | -$191.00M |
| EPS (basic) | -1.1400 | -2.7700 | -6.6200 | -5.3100 | -3.8200 |
| EPS (diluted) | -1.1400 | -2.7700 | -6.6200 | -5.3100 | -3.8200 |
| Shares (diluted) | $70.90M | $71.90M | $55.50M | $53.20M | $50.00M |